cetirizine 2.4 MG/ML Ophthalmic Solution

RxCUI: 2119476
RxNorm name: cetirizine 2.4 MG/ML Ophthalmic Solution
Display name: cetirizine 2.4 MG/ML Ophthalmic Solution
Full name: cetirizine 2.4 MG/ML Ophthalmic Solution
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZERVIATE	CETIRIZINE	Harrow Eye, LLC	6fc5ef4e-4aea-4c34-8d51-0c07ab9aad59	2025-04-23	Warnings, Adverse reactions	Exact identifier rxcui: 2119476

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
3e6fecc1-df71-4c01-a654-f55635617a7f	cetirizine 0.24 % Ophthalmic Solution	PSN	11	ZERVIATE™ (cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use These highlights do not include all the information needed to use ZERVIATE safely and effectively. See full prescribing information for ZERVIATE. Initial U.S. Approval: 1995	20231009
3e6fecc1-df71-4c01-a654-f55635617a7f	cetirizine 2.4 MG (as cetirizine HCl 2.85 MG) per 1 ML Ophthalmic Solution	SY	11	ZERVIATE™ (cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use These highlights do not include all the information needed to use ZERVIATE safely and effectively. See full prescribing information for ZERVIATE. Initial U.S. Approval: 1995	20231009
3e6fecc1-df71-4c01-a654-f55635617a7f	cetirizine 0.24 % Ophthalmic Solution	SY	11	ZERVIATE™ (cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use These highlights do not include all the information needed to use ZERVIATE safely and effectively. See full prescribing information for ZERVIATE. Initial U.S. Approval: 1995	20231009
3e6fecc1-df71-4c01-a654-f55635617a7f	cetirizine 2.4 MG/ML Ophthalmic Solution	SCD	11	ZERVIATE™ (cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use These highlights do not include all the information needed to use ZERVIATE safely and effectively. See full prescribing information for ZERVIATE. Initial U.S. Approval: 1995	20231009
6fc5ef4e-4aea-4c34-8d51-0c07ab9aad59	cetirizine 0.24 % Ophthalmic Solution	PSN	2	These highlights do not include all the information needed to use ZERVIATE ® safely and effectively. See full prescribing information for ZERVIATE ® . ZERVIATE ® (cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use Initial U.S. Approval: 1995	20250423
6fc5ef4e-4aea-4c34-8d51-0c07ab9aad59	cetirizine 2.4 MG (as cetirizine HCl 2.85 MG) per 1 ML Ophthalmic Solution	SY	2	These highlights do not include all the information needed to use ZERVIATE ® safely and effectively. See full prescribing information for ZERVIATE ® . ZERVIATE ® (cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use Initial U.S. Approval: 1995	20250423
6fc5ef4e-4aea-4c34-8d51-0c07ab9aad59	cetirizine 2.4 MG/ML Ophthalmic Solution	SCD	2	These highlights do not include all the information needed to use ZERVIATE ® safely and effectively. See full prescribing information for ZERVIATE ® . ZERVIATE ® (cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use Initial U.S. Approval: 1995	20250423
6fc5ef4e-4aea-4c34-8d51-0c07ab9aad59	cetirizine 0.24 % Ophthalmic Solution	SY	2	These highlights do not include all the information needed to use ZERVIATE ® safely and effectively. See full prescribing information for ZERVIATE ® . ZERVIATE ® (cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use Initial U.S. Approval: 1995	20250423